LAST UPDATED: Jan. 3, 2021, 4:11 p.m.
NEW DELHI (DIVYA SAINI): Drugs Controller General of India (DCGI) VG Somani has approved the Bharat Biotech and Oxford-AstraZeneca COVID vaccines on Sunday. Somani made an official announcement of approving Serum Institute of India and Oxford-AstraZeneca vaccine for restricted emergency use in the country.
“After adequate examination, CDSCO has decided to accept the recommendations of the Expert Committee and accordingly, vaccines of M/s Serum and M/s Bharat Biotech are being approved for restricted use in emergency situations,” Somani said in a press conference.
“We’ll never approve anything if there is slightest of safety concern. The vaccines are 100 per cent safe. Some side effects like mild fever, pain and allergy are common for every vaccine. It is absolute rubbish that people may become impotent,” he said as quoted by ANI.
Both the vaccines are said to be 100 per cent safe and if there were slightest safety they would have never approved as said by Somani. The vaccine has certain side effects like mild fever, pain and allergy but these are common symptoms for every vaccine.
Soon after the approval by DCGI approved the Serum’s ‘Covishield’ and Bharat Biotech’s ‘Covaxin’ vaccines Prime Minister Narendra Modi congratulated the drugs regulator and scientists who worked day and night to develop the Covid-19 vaccines. PM Modi also said that both the vaccines will be manufactured in India. He also said that the approval has accelerated the road to a healthier and coronavirus-free nation. He also said that this is how much eager scientists were to fulfill the dream of Aatmanirbhar Bharat.
“It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! This shows the eagerness of our scientific community to fulfil the dream of an Aatmanirbhar Bharat, at the root of which is care and compassion,” Prime minister tweeted.
Image credits: Google